Dramatic Response of BRAF V600E-mutant Epithelioid Glioblastoma to Combination Therapy with BRAF and MEK Inhibitor: Establishment and Xenograft of a Cell Line to Predict Clinical Efficacy.
Acta neuropathologica communications(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要